Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Parrott

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Journal of Pharmaceutical Sciences|September 2, 2005
An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discoveryNeil Parrott, Nicolas Paquereau, Philippe Coassolo, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 1, 2019
Application of New Cellular and Microphysiological Systems to Drug Metabolism Optimization and Their Positioning Respective to In Silico ToolsLuca Docci, Neil Parrott, Stephan Krähenbühl, et al.
Pharmaceutics|January 21, 2023
Physiologically Based Biopharmaceutics Modeling of Food Effect for Basmisanil: A Retrospective Case Study of the Utility for Formulation BridgingTejashree Belubbi, Davide Bassani, Cordula Stillhart, et al.
The AAPS Journal|October 4, 2017
Investigating Oral Absorption of Carbamazepine in Pediatric PopulationsPhilip Kohlmann, Cordula Stillhart, Martin Kuentz, et al.
Drug Discovery Today. Technologies|December 17, 2016
Translational PK/PD modeling to increase probability of success in drug discovery and early developmentThierry Lavé, Antonello Caruso, Neil Parrott, et al.
Clinical Pharmacology and Therapeutics|April 28, 2025
Prospective DDI Risk Assessment of Vicasinabin with PBPK Modeling by Integrating In Vitro DataKenichi Umehara, Neil Parrott, Andreas Günther, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 13, 2005
A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog studyMartin Kuentz, Sonja Nick, Neil Parrott, et al.
Clinical Pharmacokinetics|April 28, 2006
A novel strategy for physiologically based predictions of human pharmacokineticsHannah M Jones, Neil Parrott, Karin Jorga, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 18, 2022
Introduction of an artificial neural network-based method for concentration-time predictionsDominic Stefan Bräm, Neil Parrott, Lucy Hutchinson, et al.
Clinical Pharmacokinetics|November 23, 2006
Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modellingHannah M Jones, Neil Parrott, Gerd Ohlenbusch, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Journal of Pharmaceutical Sciences|September 2, 2005
An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discoveryNeil Parrott, Nicolas Paquereau, Philippe Coassolo, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 1, 2019
Application of New Cellular and Microphysiological Systems to Drug Metabolism Optimization and Their Positioning Respective to In Silico ToolsLuca Docci, Neil Parrott, Stephan Krähenbühl, et al.
Pharmaceutics|January 21, 2023
Physiologically Based Biopharmaceutics Modeling of Food Effect for Basmisanil: A Retrospective Case Study of the Utility for Formulation BridgingTejashree Belubbi, Davide Bassani, Cordula Stillhart, et al.
The AAPS Journal|October 4, 2017
Investigating Oral Absorption of Carbamazepine in Pediatric PopulationsPhilip Kohlmann, Cordula Stillhart, Martin Kuentz, et al.
Drug Discovery Today. Technologies|December 17, 2016
Translational PK/PD modeling to increase probability of success in drug discovery and early developmentThierry Lavé, Antonello Caruso, Neil Parrott, et al.
Clinical Pharmacology and Therapeutics|April 28, 2025
Prospective DDI Risk Assessment of Vicasinabin with PBPK Modeling by Integrating In Vitro DataKenichi Umehara, Neil Parrott, Andreas Günther, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 13, 2005
A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog studyMartin Kuentz, Sonja Nick, Neil Parrott, et al.
Clinical Pharmacokinetics|April 28, 2006
A novel strategy for physiologically based predictions of human pharmacokineticsHannah M Jones, Neil Parrott, Karin Jorga, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 18, 2022
Introduction of an artificial neural network-based method for concentration-time predictionsDominic Stefan Bräm, Neil Parrott, Lucy Hutchinson, et al.
Clinical Pharmacokinetics|November 23, 2006
Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modellingHannah M Jones, Neil Parrott, Gerd Ohlenbusch, et al.
Pageof 13